Heptares Therapeutics Free Archived

Info

Please note that for mobiles we stream the presentation slides and audio of the speaker.

Info

This video has been archived as it is more than 2 years old. CPD is no longer available.

x Mobile version: slides + audio only
-15s 00:00 / 17:42 +15s
Minimise video

Heptares Therapeutics discovers and develops new medicines targeting GPCRs (G protein-coupled receptors), a super-family of drug targets linked to a wide range of human diseases. The company is an industry pioneer in GPCR structure-based drug design and has built a unique capability for discovering novel molecules that target historically undruggable or challenging GPCRs. Its integrated discovery platform has enabled it to generate a broad pipeline of novel drugs directed towards these targets, which it is developing for the treatment of a number of diseases. 

This lecture was part of an event called ‘Medical Innovations Summit’ at The Royal Society of Medicine in London.

Date of lecture: 5th July 2014 

This video is available for iPad via Safari

Length: 00:17:42

00:00:01 - Introduction
00:06:18 - Foundation of Heptares
00:12:05 - Alzheimer Disease
00:16:30 - Conclusion
00:00:01
00:00:03
00:00:43
00:01:45
00:03:40
00:06:18
00:08:10
00:08:46
00:09:53
00:10:54
00:12:00
00:12:05
00:13:03
00:14:15
00:15:00
00:15:40
00:16:30
00:17:40
51:06

Professor Sir Mark Walport, Director of the Wellcome Trust.

Archived View
35:53

Mr Ben Challacombe, Consultant Urological Surgeon at Guy's and St Thomas' NHS Foundation Trust.

 

Free Archived View
38:25

Professor Tom Waddell, Professor of Thoracic and Lung Transplant Surgery, University of Toronto.

Archived View
25:30

Professor Adrian Hill, Chairman of the Centre for Clinical Vaccinology and Tropical Medicine at Oxford University. 

Free Archived View
28:05

Dr Alun Morgan and Mrs Gill Davies, ZooBiotic.

Free Archived View
26:45

Dr Paul Sobotka, Ardian, California and Dr Mel Lobo, Barts and the London NHS Trust. 

Free Archived View
29:24

Peter Suma and Peter Ellis, Pharmatrust, Canada and the UK.

Free Archived View
37:46

Dr Frederic Moll, President and CEO Hansen Medical Inc, California.

Free Archived View
16:14

Professor Anan Shetty, Senior tutor in orthopaedics, University of London. 

Free Archived View